Literature DB >> 20458317

Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.

Yan Yu1, Hong Jin, Daniel Holder, Josef S Ozer, Stephanie Villarreal, Paul Shughrue, Shu Shi, David J Figueroa, Holly Clouse, Ming Su, Nagaraja Muniappa, Sean P Troth, Wendy Bailey, John Seng, Amy G Aslamkhan, Douglas Thudium, Frank D Sistare, David L Gerhold.   

Abstract

The capacities of urinary trefoil factor 3 (TFF3) and urinary albumin to detect acute renal tubular injury have never been evaluated with sufficient statistical rigor to permit their use in regulated drug development instead of the current preclinical biomarkers serum creatinine (SCr) and blood urea nitrogen (BUN). Working with rats, we found that urinary TFF3 protein levels were markedly reduced, and urinary albumin were markedly increased in response to renal tubular injury. Urinary TFF3 levels did not respond to nonrenal toxicants, and urinary albumin faithfully reflected alterations in renal function. In situ hybridization localized TFF3 expression in tubules of the outer stripe of the outer medulla. Albumin outperformed either SCr or BUN for detecting kidney tubule injury and TFF3 augmented the potential of BUN and SCr to detect kidney damage. Use of urinary TFF3 and albumin will enable more sensitive and robust diagnosis of acute renal tubular injury than traditional biomarkers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458317     DOI: 10.1038/nbt.1624

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  48 in total

1.  Towards consensus practices to qualify safety biomarkers for use in early drug development.

Authors:  Frank D Sistare; Frank Dieterle; Sean Troth; Daniel J Holder; David Gerhold; Dina Andrews-Cleavenger; William Baer; Graham Betton; Denise Bounous; Kevin Carl; Nathaniel Collins; Peter Goering; Federico Goodsaid; Yi-Zhong Gu; Valerie Guilpin; Ernie Harpur; Alita Hassan; David Jacobson-Kram; Peter Kasper; David Laurie; Beatriz Silva Lima; Romaldas Maciulaitis; William Mattes; Gérard Maurer; Leslie Ann Obert; Josef Ozer; Marisa Papaluca-Amati; Jonathan A Phillips; Mark Pinches; Matthew J Schipper; Karol L Thompson; Spiros Vamvakas; Jean-Marc Vidal; Jacky Vonderscher; Elizabeth Walker; Craig Webb; Yan Yu
Journal:  Nat Biotechnol       Date:  2010-05-10       Impact factor: 54.908

2.  Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family.

Authors:  S Suemori; K Lynch-Devaney; D K Podolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 3.  Translational toxicology and the work of the predictive safety testing consortium.

Authors:  W B Mattes; E G Walker
Journal:  Clin Pharmacol Ther       Date:  2009-01-21       Impact factor: 6.875

4.  Use of single voided urine samples to estimate quantitative proteinuria.

Authors:  J M Ginsberg; B S Chang; R A Matarese; S Garella
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

5.  Down-regulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factors.

Authors:  Veronika Dossinger; Tuncay Kayademir; Nikolaus Blin; Peter Gött
Journal:  Cell Physiol Biochem       Date:  2002

6.  Trefoil factor family 3 peptide promotes human airway epithelial ciliated cell differentiation.

Authors:  Pierre LeSimple; Isabelle van Seuningen; Marie-Pierre Buisine; Marie-Christine Copin; Margitta Hinz; Werner Hoffmann; Rodolphe Hajj; Steven L Brody; Christelle Coraux; Edith Puchelle
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-28       Impact factor: 6.914

7.  Altered expression of trefoil factor 3 and cathepsin L gene in rat kidney during aging.

Authors:  Priya Ranjan Debata; Harekrushna Panda; Prakash C Supakar
Journal:  Biogerontology       Date:  2006-07-25       Impact factor: 4.277

8.  D-serine-induced nephrotoxicity: possible interaction with tyrosine metabolism.

Authors:  R E Williams; E A Lock
Journal:  Toxicology       Date:  2004-09-01       Impact factor: 4.221

9.  Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide.

Authors:  M B Loncar; E-d Al-azzeh; P S M Sommer; M Marinovic; K Schmehl; M Kruschewski; N Blin; R Stohwasser; P Gött; T Kayademir
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

10.  Expression and purification of a trefoil peptide motif in a beta-galactosidase fusion protein and its use to search for trefoil-binding sites.

Authors:  R Chinery; R Poulsom; G Elia; A M Hanby; N A Wright
Journal:  Eur J Biochem       Date:  1993-03-01
View more
  65 in total

1.  Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury.

Authors:  Frank Dieterle; Elias Perentes; André Cordier; Daniel R Roth; Pablo Verdes; Olivier Grenet; Serafino Pantano; Pierre Moulin; Daniel Wahl; Andreas Mahl; Peter End; Frank Staedtler; François Legay; Kevin Carl; David Laurie; Salah-Dine Chibout; Jacky Vonderscher; Gérard Maurer
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.

Authors:  Josef S Ozer; Frank Dieterle; Sean Troth; Elias Perentes; André Cordier; Pablo Verdes; Frank Staedtler; Andreas Mahl; Olivier Grenet; Daniel R Roth; Daniel Wahl; François Legay; Daniel Holder; Zoltan Erdos; Katerina Vlasakova; Hong Jin; Yan Yu; Nagaraja Muniappa; Tom Forest; Holly K Clouse; Spencer Reynolds; Wendy J Bailey; Douglas T Thudium; Michael J Topper; Thomas R Skopek; Joseph F Sina; Warren E Glaab; Jacky Vonderscher; Gérard Maurer; Salah-Dine Chibout; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

3.  Towards consensus practices to qualify safety biomarkers for use in early drug development.

Authors:  Frank D Sistare; Frank Dieterle; Sean Troth; Daniel J Holder; David Gerhold; Dina Andrews-Cleavenger; William Baer; Graham Betton; Denise Bounous; Kevin Carl; Nathaniel Collins; Peter Goering; Federico Goodsaid; Yi-Zhong Gu; Valerie Guilpin; Ernie Harpur; Alita Hassan; David Jacobson-Kram; Peter Kasper; David Laurie; Beatriz Silva Lima; Romaldas Maciulaitis; William Mattes; Gérard Maurer; Leslie Ann Obert; Josef Ozer; Marisa Papaluca-Amati; Jonathan A Phillips; Mark Pinches; Matthew J Schipper; Karol L Thompson; Spiros Vamvakas; Jean-Marc Vidal; Jacky Vonderscher; Elizabeth Walker; Craig Webb; Yan Yu
Journal:  Nat Biotechnol       Date:  2010-05-10       Impact factor: 54.908

4.  A roadmap for biomarker qualification.

Authors:  David G Warnock; Carl C Peck
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

5.  Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Authors:  Nathaniel J Rhodes; Walter C Prozialeck; Thomas P Lodise; Natarajan Venkatesan; J Nicholas O'Donnell; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Michael N Neely; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

6.  The urinary levels of prostanoid metabolites predict acute kidney injury in heterogeneous adult Japanese ICU patients: a prospective observational study.

Authors:  Haruyo Ujike-Omori; Yohei Maeshima; Masaru Kinomura; Katsuyuki Tanabe; Kiyoshi Mori; Hiroyuki Watatani; Norikazu Hinamoto; Hitoshi Sugiyama; Yoshiki Sakai; Hiroshi Morimatsu; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2015-02-11       Impact factor: 2.801

Review 7.  Established and emerging markers of kidney function.

Authors:  Michael A Ferguson; Sushrut S Waikar
Journal:  Clin Chem       Date:  2012-02-06       Impact factor: 8.327

8.  Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.

Authors:  Yoshiki Taniguchi; Yukinori Kurokawa; Tsuyoshi Takahashi; Jota Mikami; Yasuhiro Miyazaki; Koji Tanaka; Tomoki Makino; Makoto Yamasaki; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

Review 9.  Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development.

Authors:  Leonie van Meer; Matthijs Moerland; Adam F Cohen; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

Review 10.  Biomarkers in nephrology: Core Curriculum 2013.

Authors:  Gearoid M McMahon; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2013-02-27       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.